Novel tricyclic compounds are disclosed having the general structure of Formulas I or II: ##STR00001## were R1, R2 and R3 are defined in the written description of the invention. The compounds are useful for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by intracellular cytokine signaling.